NATIONAL INSTRUMENTS CORPORATION 
By AUSTIN, Texas, Jan. 30, 2014 /PRNewswire/ -- National Instruments (Nasdaq: NATI) today announced Q4 revenue of $301 million, flat year-over year. The company's orders under $20,000 grew approximately 3 percent year-over-year; orders between $20,000 and $100,000 increased approximately 1 percent year-over-year; and orders above $100,000 decreased about 9 percent year-over-year. In Q4 2013, NI recognized $4 million in revenue from its largest customer, compared with approximately $16 million recognized in Q4 2012.
GAAP net income for Q4 was $32 million, with fully diluted earnings per share (EPS) of $0.25, and non-GAAP net income was $39 million, with non-GAAP fully diluted EPS of $0.31. EBITDA, or Earnings Before Interest, Taxes, Depreciation and Amortization, was $56 million, or $0.44 per share for Q4.
In Q4, GAAP gross margin increased to 75 percent and non-GAAP gross margin was 76 percent, up 70 basis points from Q3 2013. Total GAAP operating expenses were down 4 percent sequentially and were down 6 percent year-over-year. Total non-GAAP operating expenses were down approximately 4 percent sequentially and were down 3 percent year-over-year.
GAAP operating margin was 13 percent in Q4, with GAAP operating income of $40 million, up 93 percent sequentially and up 42 percent year-over-year. Non-GAAP operating margin was 17 percent in Q4, with non-GAAP operating income of $51 million, up 56 percent sequentially and up 12 percent year-over-year.
The company's non-GAAP results exclude the impact of stock-based compensation, amortization of acquisition-related intangibles, acquisition accounting for deferred revenue, acquisition-related adjustments and acquisition-related transaction costs. Reconciliations of the company's GAAP and non-GAAP results are included as part of this news release.
"In 2013, NI continued to advance our software-based approach for test and measurement and deliver our 35(th) year of growth despite weakness in the industry," said Dr. James Truchard, NI president, CEO and co-founder. "I believe we have made the investments necessary to build on our highly differentiated platform and I am focused on developing our high-performance management team in our quest to reach our goal of $2 billion in annual revenue."
Geographic revenue in U.S. dollar terms for Q4 2013 compared to Q4 2012 was up 6 percent in the Americas and up 14 percent in Europe. However, revenue declined 15 percent in East Asia because the majority of revenue from the company's largest customer is recognized in this region, and revenue was down 20 percent year-over-year in Emerging Markets primarily from a significant decline in orders over $100,000. In local currency terms, revenue was up 11 percent in Europe, down 13 percent in East Asia and down 14 percent in Emerging Markets.
As of Dec. 31, NI had $393 million in cash and short-term investments, up $49 million from Sept. 30, 2013. The NI Board of Directors also approved an increase in the quarterly dividend to $0.15 per share on the company's common stock payable on March 10 to stockholders of record on Feb. 18.
FY 2013 Highlights
-- Record revenue of $1.17 billion, up 3 percent year-over-year
-- Strong growth in RF and CompactRIO products
-- Fully diluted GAAP EPS of $0.64 and fully diluted non-GAAP EPS of $0.88
-- NI named to the Great Place to Work Institute's 25 Best Multinational
Companies to Work For list for the third consecutive year and its 100
Best Companies to Work For list for the 15th consecutive year
-- EBITDA of $164 million, or $1.31 per share
-- Dividend of $0.56 per share
Full-year 2013 revenue was $1.17 billion, up 3 percent year-over-year. GAAP net income for 2013 was $81 million, with fully diluted GAAP EPS of $0.64, and non-GAAP net income was $110 million, with fully diluted EPS of $0.88.
"We believe our ability to gain market share despite challenges in the test and measurement industry demonstrated the strength of our disruptive approach," said Alex Davern, NI COO and CFO. "Our goals for 2014 are to continue to leverage the investments we have already made to drive sustained revenue growth and to continue to drive toward our long-term target of 18 percent non-GAAP operating margin."
Guidance for Q1 2014
Though pleased to see the recent recovery in the Global PMI, NI continues to be conservative in planning for the first half of 2014 because it believes customers are being cautious about their capital spending. NI currently expects revenue for Q1 2014 to be between $272 million and $302 million. NI expects fully diluted EPS to be in the range of $0.09 to $0.21 for Q1, with non-GAAP fully diluted EPS expected to be in the range of $0.15 to $0.27. The company's non-GAAP tax rate in Q1 2013 was 10 percent as a result of the retroactive renewal of the R&D tax credit in January 2013. For 2014, the R&D tax credit has not yet been approved and as a result, NI expects its non-GAAP effective tax rate for Q1 2014 to be approximately 24 percent.
Non-GAAP Presentation
In addition to disclosing results determined in accordance with GAAP, NI discloses certain non-GAAP operating results and non-GAAP information that exclude certain charges. In this news release, the company has presented its gross profit, gross margin, operating expenses, operating income, operating margin, income before income taxes, provision for income taxes, net income and basic and fully diluted EPS for the three- and 12-month periods ending Dec. 31, 2013 and 2012, on a GAAP and non-GAAP basis. NI is also providing guidance on its non-GAAP fully diluted EPS.
When presenting non-GAAP information, the company includes a reconciliation of the non-GAAP results to the GAAP results. Management believes that including the non-GAAP results assists investors in assessing the company's operational performance and its performance relative to its competitors. The company presents these non-GAAP results as a complement to results provided in accordance with GAAP, and these results should not be regarded as a substitute for GAAP. Management uses these non-GAAP measures to manage and assess the profitability and performance of its business and does not consider stock-based compensation expense, amortization of acquisition-related intangibles, acquisition accounting for deferred revenue, acquisition-related adjustments and acquisition-related transaction costs in managing its operations. Specifically, management uses non-GAAP measures to plan and forecast future periods, to establish operational goals, to compare with its business plan and individual operating budgets, to measure management performance for the purposes of executive compensation including payments to be made under bonus plans, to assist the public in measuring the company's performance relative to the company's long-term public performance goals, to allocate resources and, relative to the company's historical financial performance, to enable comparability between periods. Management also considers such non-GAAP results to be an important supplemental measure of its performance.
This news release also discloses the company's EBITDA and EBITDA diluted EPS for the three- and 12-month periods ending Dec. 31, 2013 and 2012. The company also believes that including the EBITDA results assists investors in assessing the company's operational performance relative to its competitors. A reconciliation of EBITDA and EBITDA diluted EPS to GAAP net income and GAAP diluted EPS is included with this news release.
Conference Call Information and Availability of Presentation Materials
Interested parties can listen to the Q4 2013 conference call today, Jan. 30, at 4:00 p.m. CT at ni.com/call. Replay information is available by calling (855) 859-2056, confirmation code # 29987892, shortly after the call through Feb. 4 at 3:00 p.m. CT, or by visiting the company's website at ni.com/call. You may also view certain presentation materials that we may refer to on the conference call at ni.com/nati.
Forward-Looking Statements
This release contains "forward-looking statements," including statements regarding NI making the investments necessary to build on its highly differentiated platform; the company's focus on developing its high-performance management team in its quest to reach its goal of $2 billion in annual revenue; the strength of the company's disruptive approach; goals to continue to leverage investments it already made to drive sustained revenue growth; NI's drive toward its long-term goal of 18 percent non-GAAP operating margin; the company being conservative in planning for the first half of 2014; customers being cautious in their capital spending; and NI's Q1 guidance for revenue, GAAP and non-GAAP EPS, and non-GAAP tax rate. These statements are subject to a number of risks and uncertainties, including the risk of adverse changes or fluctuations in the global economy, U.S. budgetary or debt issues, foreign exchange fluctuations, component shortages, delays in the release of new products, fluctuations in customer demand for NI products including orders from NI's
largest customer, fluctuations in average order size and customer mix, the company's ability to effectively manage its operating expenses, manufacturing inefficiencies and the level of capacity utilization and the impact of any acquisitions by NI. Actual results may differ materially from the expected results.
The company directs readers to its Form 10-K for the fiscal year ended Dec. 31, 2012; its Form 10-Q for the quarter ended Sept. 30, 2013; and the other documents it files with the SEC for other risks associated with the company's future performance.
About National Instruments
Since 1976, National Instruments (www.ni.com) has equipped engineers and scientists with tools that accelerate productivity, innovation and discovery. NI's graphical system design approach to engineering provides an integrated software and hardware platform that speeds the development of any system needing measurement and control. The company's long-term vision and focus on improving society through its technology supports the success of its customers, employees, suppliers and shareholders. Readers can obtain investment information from the company's investor relations department by calling (512) 683-5090, emailing nati@ni.com or visiting www.ni.com/nati. (NATI-F)
CompactRIO, LabVIEW, National Instruments, NI, ni.com and NICompactDAQ are trademarks of National Instruments. Other product and company names listed are trademarks or trade names of their respective companies.
Contact: Caitlin Gursslin, Investor Relations, caitlin.gursslin@ni.com
National Instruments
Condensed Consolidated Balance Sheets
(in thousands)
Dec. 31, Dec. 31,
2013 2012
---- ----
(unaudited)
Assets
Current assets:
Cash and cash equivalents $230,263 $161,996
Short-term investments 163,149 173,166
Accounts receivable, net 180,680 187,060
Inventories, net 172,109 169,990
Prepaid expenses and other current assets 49,001 48,009
Deferred income taxes, net 33,393 27,479
------ ------
Total current assets 828,595 767,700
Property and equipment, net 260,568 249,721
Goodwill 146,520 147,258
Intangible assets, net 82,310 93,913
Other long-term assets 25,558 26,177
Total assets $1,343,551 $1,284,769
Liabilities and Stockholders' Equity
Current liabilities:
Accounts payable $56,614 $65,080
Accrued compensation 25,189 29,978
Deferred revenue - current 96,117 90,714
Accrued expenses and other liabilities 17,627 34,373
Other taxes payable 29,808 24,811
------ ------
Total current liabilities 225,355 244,956
Deferred income taxes 44,620 47,630
Liability for uncertain tax positions 23,572 20,920
Deferred revenue - long-term 21,389 20,446
Other long-term liabilities 5,531 11,689
------
Total liabilities $320,467 $345,641
Stockholders' equity:
Preferred stock - -
Common stock 1,257 1,229
Additional paid-in capital 604,330 532,845
Retained earnings 414,947 404,210
Accumulated other comprehensive income 2,550 844
---
Total stockholders' equity $1,023,084 $939,128
Total liabilities and stockholders' equity $1,343,551 $1,284,769
National Instruments
Condensed Consolidated Statements of Income
(in thousands, except per share data)
Three Months Ended 12 Months Ended
Dec. 31, Dec. 31,
2013 2012 2013 2012
---- ---- ---- ----
(unaudited) (unaudited)
Net sales:
Product $280,523 $278,641 $1,091,186 $1,054,849
Software maintenance 20,283 21,685 81,372 87,494
GSA accrual - - - 1,349
Total net sales 300,806 300,326 1,172,558 1,143,692
Cost of sales:
Product 74,900 73,465 299,854 274,839
Software maintenance 1,082 1,116 5,389 5,435
----- ----- ----- -----
Total cost of sales 75,982 74,581 305,243 280,274
Gross profit 224,824 225,745 867,315 863,418
------- ------- ------- -------
Operating expenses:
Sales and marketing 109,916 111,447 447,800 431,468
Research and development 54,276 58,066 234,796 222,994
General and administrative 21,055 21,649 87,418 85,239
Acquisition-related adjustment - 6,783 (1,316) 6,783
Total operating expenses 185,247 197,945 768,698 746,484
------- ------- ------- -------
Operating income 39,577 27,800 98,617 116,934
Other income (expense):
Interest income 184 221 679 716
Net foreign exchange loss (521) (107) (2,578) (2,246)
Other income (expense), net (278) 77 450 (567)
---- --- --- ----
Income before income taxes 38,962 27,991 97,168 114,837
Provision for income taxes 7,234 7,278 16,655 24,700
----- ----- ------ ------
Net income $31,728 $20,713 $80,513 $90,137
Basic earnings per share $0.25 $0.17 $0.65 $0.74
Diluted earnings per share $0.25 $0.17 $0.64 $0.73
Weighted average shares outstanding -
Basic 125,489 122,754 124,558 121,973
Diluted 126,217 123,375 125,571 122,977
Dividends declared per share $0.14 $ $0.14 $0.56 $ $0.56
National Instruments
Condensed Consolidated Statements of Cash Flows
(in thousands)
12 months ended
Dec. 31,
2013 2012
---- ----
(unaudited)
Cash flow from operating activities:
Net income $80,513 $90,137
Adjustments to reconcile net income to net cash provided
by operating activities:
Depreciation and amortization 67,974 58,686
Stock-based compensation 28,992 27,796
Tax (benefit) expense from deferred income taxes (4,353) 1,853
Tax benefit from stock option plans (2,407) (2,198)
Changes in operating assets and liabilities:
Accounts receivable 6,820 (26,007)
Inventories (1,563) (36,154)
Prepaid expenses and other assets (1,767) (7,037)
Accounts payable (8,604) 23,419
Deferred revenue 6,346 21,050
Taxes and other liabilities (2,427) (19,029)
Net cash provided by operating activities 169,524 132,516
------- -------
Cash flow from investing activities:
Capital expenditures (47,796) (89,073)
Capitalization of internally developed software (14,883) (11,721)
Additions to other intangibles (5,182) (1,890)
Acquisitions, net of cash received - (25,481)
Purchases of short-term investments (70,354) (188,098)
Sales and maturities of short-term investments 80,371 238,436
Net cash used by investing activities (57,844) (77,827)
------- -------
Cash flow from financing activities:
Proceeds from issuance of common stock 39,319 30,902
Deferred acquisition payments (15,318) -
Dividends paid (69,821) (68,401)
Tax benefit from stock option plans 2,407 2,198
Net cash used by financing activities (43,413) (35,301)
------- -------
Net change in cash and cash equivalents 68,267 19,388
Cash and cash equivalents at beginning of period 161,996 142,608
Cash and cash equivalents at end of period $230,263 $161,996
National Instruments
Detail of GAAP Charges Related to Revenue, Stock-Based Compensation,
Amortization of Acquisition Intangibles and Acquisition-Related Transaction Costs
(in thousands)
(unaudited)
Three Months Ended 12 Months Ended
Dec. 31, Dec. 31,
2013 2012 2013 2012
---- ---- ---- ----
Revenue
Acquisition-related deferred revenue $ - $ - $ - $2,156
GSA accrual - - - (1,349)
--- --- --- ------
Provision for income taxes - - - (282)
--- --- --- ----
Total $ - $ - $ - $525
--- --- ---
Stock-Based Compensation
Cost of sales $439 $430 $1,658 $1,719
Sales and marketing 2,882 3,033 11,789 11,612
Research and development 2,728 2,919 11,864 10,909
General and administrative 890 908 3,624 3,556
--- --- ----- -----
Provision for income taxes (3,216) (2,193) (9,801) (7,579)
------ ------ ------ ------
Total $3,723 $5,097 $19,134 $20,217
Amortization of Acquisition Intangibles
Cost of sales $2,673 $2,165 $10,718 $8,926
Sales and marketing 482 476 1,988 1,819
Research and development 405 217 2,043 217
Other income, net 185 194 751 765
Provision for income taxes (1,231) (964) (5,081) (3,717)
------ ---- ------ ------
Total 2,514 $2,088 $10,419 $8,010
----- ------ ------- ------
Acquisition-Related Adjustment and Transaction Costs
Cost of sales $21 $(56) $28 $(24)
Sales and marketing 189 177 595 606
Research and development 410 165 1,101 360
General and administrative 80 355 326 393
Acquisition-related adjustment - 6,783 (1,316) 6,783
--- ----- ------ -----
Provision for income taxes (133) (105) (545) (348)
---- ---- ---- ----
Total $567 $7,319 $189 $7,770
National Instruments
Reconciliation of GAAP to Non-GAAP Measures
(in thousands, except per share data)
(unaudited)
Three Months Ended 12 Months Ended
Dec. 31, Dec. 31,
2013 2012 2013 2012
---- ---- ---- ----
Reconciliation of Net Sales to Non-GAAP Net Sales
Net sales, as reported $300,806 $300,326 $1,172,558 $1,143,692
Acquisition-related deferred revenue - - - 2,156
GSA accrual - - - (1,349)
Non-GAAP net sales $300,806 $300,326 $1,172,558 $1,144,499
Reconciliation of Gross Profit to Non-GAAP Gross Profit
Gross profit, as reported $224,824 $225,745 $867,315 $863,418
Acquisition-related deferred revenue - - - 807
Stock-based compensation 439 430 1,658 1,719
Amortization of acquisition intangibles 2,673 2,165 10,718 8,926
Acquisition-related transaction costs 21 (56) 28 (24)
--- --- --- ---
Non-GAAP gross profit $227,957 $228,284 $879,719 $874,846
Non-GAAP gross margin 76% 76% 75% 76%
Reconciliation of Operating Expenses to Non-GAAP Operating Expenses
Operating expenses, as reported $185,247 $197,945 $768,698 $746,484
Stock-based compensation (6,500) (6,860) (27,277) (26,077)
Amortization of acquisition intangibles (887) (693) (4,031) (2,036)
Acquisition-related adjustment - (6,783) 1,316 (6,783)
Acquisition-related transaction costs (679) (697) (2,022) (1,359)
---- ---- ------ ------
Non-GAAP operating expenses $177,181 $182,912 $736,684 $710,229
Reconciliation of Operating Income to Non-GAAP Operating Income
Operating income, as reported $39,577 $27,800 $98,617 $116,934
Acquisition-related deferred revenue - - - 807
Stock-based compensation 6,939 7,290 28,935 27,796
Amortization of acquisition intangibles 3,560 2,858 14,749 10,962
Acquisition-related adjustment - 6,783 (1,316) 6,783
Acquisition-related transaction costs 700 641 2,050 1,335
--- --- ----- -----
Non-GAAP operating income $50,776 $45,372 $143,035 $164,617
Non-GAAP operating margin 17% 15% 12% 14%
Reconciliation of Income Before Income Taxes to Non-GAAP Income Before Income Taxes
Income before income taxes, as reported $38,962 $27,991 $97,168 $114,837
Acquisition-related deferred revenue - - - 807
Stock-based compensation 6,939 7,290 28,935 27,796
Amortization of acquisition intangibles 3,745 3,052 15,500 11,727
Acquisition-related adjustment - 6,783 (1,316) 6,783
Acquisition-related transaction costs 700 641 2,050 1,335
--- --- ----- -----
Non-GAAP income before income taxes $50,346 $45,757 $142,337 $163,285
Reconciliation of Provision for Income Taxes to Non-GAAP Provision for Income Taxes
Provision for income taxes, as reported $7,234 $7,278 $16,655 $24,700
Acquisition-related deferred revenue - - - 282
Stock-based compensation 3,216 2,193 9,801 7,579
Amortization of acquisition intangibles 1,231 964 5,081 3,717
Acquisition-related adjustment and transaction costs 133 105 545 348
--- --- --- ---
Non-GAAP provision for income taxes $11,814 $10,540 $32,082 $36,626
National Instruments
Reconciliation of GAAP Net Income, Basic EPS and Diluted EPS to Non-GAAP Net Income, Basic EPS and Diluted EPS
(in thousands, except per share data)
(unaudited)
Three Months Ended 12 Months Ended
Dec. 31, Dec. 31,
2013 2012 2013 2012
---- ---- ---- ----
Net income, as reported $31,728 $20,713 $80,513 $90,137
Adjustments to reconcile net income to non-GAAP net income:
Acquisition-related deferred revenue, net of tax effect - - - 525
Stock-based compensation, net of tax effect 3,723 5,097 19,134 20,217
Amortization of acquisition intangibles, net of tax effect 2,514 2,088 10,419 8,010
Acquisition-related adjustment - 6,783 (1,316) 6,783
Acquisition-related transaction costs, net of tax effect 567 536 1,505 987
--- --- ----- ---
Non-GAAP net income $38,532 $35,217 $110,255 $126,659
Basic EPS, as reported $0.25 $0.17 $0.65 $0.74
Adjustment to reconcile basic EPS to non-GAAP basic EPS:
Impact of acquisition-related deferred revenue, net of tax effect $ - $ - $ - $ -
Impact of stock-based compensation, net of tax effect 0.03 0.04 0.16 0.16
Impact of amortization of acquisition intangibles, net of tax effect 0.02 0.02 0.08 0.07
Acquisition-related adjustment - 0.06 (0.01) 0.06
Impact of acquisition-related transaction costs, net of tax effect 0.01 - 0.01 0.01
Non-GAAP basic EPS $0.31 $0.29 $0.89 $1.04
Diluted EPS, as reported $0.25 $0.17 $0.64 $0.73
Adjustment to reconcile diluted EPS to non-GAAP diluted EPS
Impact of acquisition-related deferred revenue, net of tax effect $ - $ - $ - $ -
Impact of stock-based compensation, net of tax effect 0.03 0.04 0.16 0.16
Impact of amortization of acquisition intangibles, net of tax effect 0.02 0.02 0.08 0.07
Acquisition-related adjustment - 0.06 (0.01) 0.06
Impact of acquisition-related transaction costs, net of tax effect 0.01 - 0.01 0.01
Non-GAAP diluted EPS $0.31 $0.29 $0.88 $1.03
Weighted average shares outstanding -
Basic 125,489 122,754 124,558 121,973
------- ------- ------- -------
Diluted 126,217 123,375 125,571 122,977
------- ------- ------- -------
National Instruments
Reconciliation of Net Income and Diluted EPS to EBITDA and EBITDA Diluted EPS
(unaudited)
Three Months Ended 12 Months Ended
Dec. 31, Dec. 31,
2013 2012 2013 2012
---- ---- ---- ----
Net income, as reported $31,728 $20,713 $80,513 $90,137
Adjustments to reconcile net income to EBITDA:
Interest income (184) (221) (679) (716)
Tax expense 7,234 7,278 16,655 24,700
Depreciation and amortization 17,077 17,657 67,974 58,686
EBITDA $55,855 $45,427 $164,463 $172,807
Diluted EPS, as reported $0.25 $0.17 $0.64 $0.73
Adjustment to reconcile diluted EPS to EBITDA
Interest income - - - -
Taxes 0.05 0.06 0.13 0.20
Depreciation and amortization 0.14 0.14 0.54 0.48
EBITDA diluted EPS $0.44 $0.37 $1.31 $1.41
Weighted average shares outstanding - diluted 126,217 123,375 125,571 122,977
------- ------- ------- -------
Reconciliation of GAAP to Non-GAAP EPS Guidance
(unaudited)
Three Months Ended
March 31, 2014
--------------
Low High
GAAP fully diluted EPS, guidance $0.09 $0.21
Adjustment to reconcile diluted EPS to non-GAAP
diluted EPS:
Impact of stock-based compensation, net of tax effect 0.04 0.04
Impact of amortization of acquisition intangibles, net of tax effect 0.02 0.02
Non-GAAP diluted EPS, guidance $0.15 $0.27
===== =====
SOURCE National Instruments
